Salipro Biotech has been granted a European Patent for its novel method of direct extraction of membrane proteins and for the generation of libraries with Salipro particles.
Swedish biotech, Salipro Biotech, has been granted a European Patent for its novel method of direct extraction of membrane proteins (DirectMX) and for the generation of libraries with Salipro particles, the company announced in a Feb. 17, 2021 press release.
The “Saposin lipoprotein particles and libraries from crude membranes” patent covers the use of DirectMX from cells or crude membranes to enable drug development of challenging drug targets. Additionally, the generation of libraries with Salipro particles representing the membrane proteome, the particles themselves, and their uses is covered.
“Ever since its inception, DirectMX has had a profound impact on how we accelerate drug discovery with our pharma partners,” said Jens Frauenfeld, CEO, Salipro Biotech in the press release. “Our foundational [intellectual property] covering the Salipro platform technology has already resulted in various patents being granted to Salipro Biotech in the [United States], [European Union], China, and Japan, and this patent will provide additional broad protection for our proprietary platform technology for the stabilization of challenging drug targets.”
Maria Knudsen, business developer, Salipro Biotech, added in the press release, “DirectMX is rapidly becoming established as a key drug discovery platform and we are already partnering with major pharma companies on a range of targets. Further strengthening our patent portfolio will enable us to increase the value of such collaborations as well as moving towards building our own discovery pipeline.”
Source: Salipro Biotech
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.